NETSCOUT SYSTEMS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NETSCOUT SYSTEMS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Mar 31, 2020 | $229.35M | May 20, 2020 |
| FY2020 | Dec 31, 2019 | $260.02M | May 20, 2020 |
| FY2020 | Sep 30, 2019 | $216.42M | May 20, 2020 |
| FY2020 | Jun 30, 2019 | $186.02M | May 20, 2020 |
| FY2020 | Mar 31, 2019 | $235.00M | May 20, 2020 |
| FY2020 | Dec 31, 2018 | $246.01M | May 20, 2020 |
| FY2020 | Sep 30, 2018 | $223.80M | May 20, 2020 |
| FY2020 | Jun 30, 2018 | $205.11M | May 20, 2020 |
| FY2019 | Mar 31, 2018 | $235.22M | May 28, 2019 |
| FY2019 | Dec 31, 2017 | $268.94M | May 28, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $822.68M | May 15, 2025 |
| FY2025 | Mar 31, 2024 | $829.46M | May 15, 2025 |
| FY2025 | Mar 31, 2023 | $914.53M | May 15, 2025 |
| FY2024 | Mar 31, 2022 | $855.58M | May 16, 2024 |
| FY2023 | Mar 31, 2021 | $831.28M | May 16, 2023 |
| FY2022 | Mar 31, 2020 | $891.82M | May 19, 2022 |
| FY2021 | Mar 31, 2019 | $909.92M | May 20, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $643.94M | May 15, 2025 |
| FY2025 | Mar 31, 2024 | $642.04M | May 15, 2025 |
| FY2025 | Mar 31, 2023 | $691.43M | May 15, 2025 |
| FY2024 | Mar 31, 2022 | $641.39M | May 16, 2024 |
| FY2023 | Mar 31, 2021 | $609.19M | May 16, 2023 |
| FY2020 | Mar 31, 2020 | $166.62M | May 20, 2020 |
| FY2020 | Dec 31, 2019 | $194.44M | May 20, 2020 |
| FY2020 | Sep 30, 2019 | $157.29M | May 20, 2020 |
| FY2020 | Jun 30, 2019 | $131.28M | May 20, 2020 |
| FY2020 | Mar 31, 2019 | $176.47M | May 20, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($366.92M) | May 15, 2025 |
| FY2025 | Mar 31, 2024 | ($147.73M) | May 15, 2025 |
| FY2025 | Mar 31, 2023 | $59.65M | May 15, 2025 |
| FY2024 | Mar 31, 2022 | $35.87M | May 16, 2024 |
| FY2023 | Mar 31, 2021 | $19.35M | May 16, 2023 |
| FY2020 | Mar 31, 2020 | $7.34M | May 20, 2020 |
| FY2020 | Dec 31, 2019 | $36.73M | May 20, 2020 |
| FY2020 | Sep 30, 2019 | ($17.47M) | May 20, 2020 |
| FY2020 | Jun 30, 2019 | ($29.34M) | May 20, 2020 |
| FY2020 | Mar 31, 2019 | $19.21M | May 20, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($367.60M) | May 15, 2025 |
| FY2025 | Mar 31, 2024 | ($149.83M) | May 15, 2025 |
| FY2025 | Mar 31, 2023 | $77.66M | May 15, 2025 |
| FY2024 | Mar 31, 2022 | $48.63M | May 16, 2024 |
| FY2023 | Mar 31, 2021 | $37.13M | May 16, 2023 |
| FY2022 | Mar 31, 2020 | $17.64M | May 19, 2022 |
| FY2021 | Mar 31, 2019 | ($71.58M) | May 20, 2021 |
| FY2020 | Mar 31, 2018 | ($4.06M) | May 20, 2020 |
| FY2019 | Mar 31, 2017 | $62.06M | May 28, 2019 |
| FY2018 | Mar 31, 2016 | ($25.55M) | May 22, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $152.86M | May 15, 2025 |
| FY2025 | Mar 31, 2024 | $161.21M | May 15, 2025 |
| FY2025 | Mar 31, 2023 | $176.17M | May 15, 2025 |
| FY2024 | Mar 31, 2022 | $171.13M | May 16, 2024 |
| FY2023 | Mar 31, 2021 | $179.16M | May 16, 2023 |
| FY2022 | Mar 31, 2020 | $188.29M | May 19, 2022 |
| FY2021 | Mar 31, 2019 | $203.59M | May 20, 2021 |
| FY2020 | Mar 31, 2018 | $215.08M | May 20, 2020 |
| FY2019 | Mar 31, 2017 | $232.70M | May 28, 2019 |
| FY2018 | Mar 31, 2016 | $208.63M | May 22, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $217.67M | May 15, 2025 |
| FY2025 | Mar 31, 2024 | $58.81M | May 15, 2025 |
| FY2025 | Mar 31, 2023 | $156.65M | May 15, 2025 |
| FY2024 | Mar 31, 2022 | $296.01M | May 16, 2024 |
| FY2023 | Mar 31, 2021 | $213.92M | May 16, 2023 |
| FY2022 | Mar 31, 2020 | $225.02M | May 19, 2022 |
| FY2021 | Mar 31, 2019 | $149.84M | May 20, 2021 |
| FY2020 | Mar 31, 2018 | $222.45M | May 20, 2020 |
| FY2019 | Mar 31, 2017 | $226.76M | May 28, 2019 |
| FY2018 | Mar 31, 2016 | $97.21M | May 22, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $5.41M | May 15, 2025 |
| FY2025 | Mar 31, 2024 | $6.36M | May 15, 2025 |
| FY2025 | Mar 31, 2023 | $10.48M | May 15, 2025 |
| FY2024 | Mar 31, 2022 | $10.35M | May 16, 2024 |
| FY2023 | Mar 31, 2021 | $11.99M | May 16, 2023 |
| FY2022 | Mar 31, 2020 | $19.92M | May 19, 2022 |
| FY2021 | Mar 31, 2019 | $23.39M | May 20, 2021 |
| FY2020 | Mar 31, 2018 | $15.91M | May 20, 2020 |
| FY2019 | Mar 31, 2017 | $29.70M | May 28, 2019 |
| FY2018 | Mar 31, 2016 | $24.78M | May 22, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $2.19B | May 15, 2025 |
| FY2025 | Mar 31, 2024 | $2.60B | May 15, 2025 |
| FY2024 | Mar 31, 2023 | $2.82B | May 16, 2024 |
| FY2023 | Mar 31, 2022 | $3.19B | May 16, 2023 |
| FY2022 | Mar 31, 2021 | $3.09B | May 19, 2022 |
| FY2021 | Mar 31, 2020 | $3.12B | May 20, 2021 |
| FY2020 | Mar 31, 2019 | $3.27B | May 20, 2020 |
| FY2019 | Mar 31, 2018 | $3.37B | May 28, 2019 |
| FY2018 | Mar 31, 2017 | $3.60B | May 22, 2018 |
| FY2017 | Mar 31, 2016 | $3.59B | May 24, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $626.18M | May 15, 2025 |
| FY2025 | Mar 31, 2024 | $703.24M | May 15, 2025 |
| FY2024 | Mar 31, 2023 | $790.91M | May 16, 2024 |
| FY2023 | Mar 31, 2022 | $1.13B | May 16, 2023 |
| FY2022 | Mar 31, 2021 | $1.08B | May 19, 2022 |
| FY2021 | Mar 31, 2020 | $1.18B | May 20, 2021 |
| FY2020 | Mar 31, 2019 | $1.20B | May 20, 2020 |
| FY2019 | Mar 31, 2018 | $1.30B | May 28, 2019 |
| FY2018 | Mar 31, 2017 | $1.17B | May 22, 2018 |
| FY2017 | Mar 31, 2016 | $1.15B | May 24, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.56B | May 15, 2025 |
| FY2025 | Mar 31, 2024 | $1.89B | May 15, 2025 |
| FY2025 | Mar 31, 2023 | $2.03B | May 15, 2025 |
| FY2025 | Mar 31, 2022 | $2.06B | May 15, 2025 |
| FY2024 | Mar 31, 2021 | $2.01B | May 16, 2024 |
| FY2023 | Mar 31, 2020 | $1.94B | May 16, 2023 |
| FY2022 | Mar 31, 2019 | $2.07B | May 19, 2022 |
| FY2021 | Mar 31, 2018 | $2.07B | May 20, 2021 |
| FY2020 | Mar 31, 2017 | $2.44B | May 20, 2020 |
| FY2019 | Mar 31, 2016 | $2.44B | May 28, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.08B | May 15, 2025 |
| FY2025 | Mar 31, 2024 | $1.50B | May 15, 2025 |
| FY2025 | Mar 31, 2023 | $1.72B | May 15, 2025 |
| FY2024 | Mar 31, 2022 | $1.72B | May 16, 2024 |
| FY2023 | Mar 31, 2021 | $1.72B | May 16, 2023 |
| FY2022 | Mar 31, 2020 | $1.73B | May 19, 2022 |
| FY2021 | Mar 31, 2019 | $1.72B | May 20, 2021 |
| FY2020 | Mar 31, 2018 | $1.71B | May 20, 2020 |
| FY2019 | Mar 31, 2017 | $1.72B | May 28, 2019 |
| FY2018 | Mar 31, 2016 | $1.71B | May 22, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($44.44M) | May 15, 2025 |
| FY2025 | Mar 31, 2024 | $322.48M | May 15, 2025 |
| FY2024 | Mar 31, 2023 | $470.21M | May 16, 2024 |
| FY2023 | Mar 31, 2022 | $410.57M | May 16, 2023 |
| FY2022 | Mar 31, 2021 | $374.69M | May 19, 2022 |
| FY2021 | Mar 31, 2020 | $355.34M | May 20, 2021 |
| FY2020 | Mar 31, 2019 | $358.09M | May 20, 2020 |
| FY2019 | Apr 1, 2018 | $431.42M | May 28, 2019 |
| FY2019 | Mar 31, 2018 | $396.49M | May 28, 2019 |
| FY2018 | Mar 31, 2017 | $316.68M | May 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $457.42M | May 15, 2025 |
| FY2025 | Mar 31, 2024 | $389.67M | May 15, 2025 |
| FY2024 | Mar 31, 2023 | $386.79M | May 16, 2024 |
| FY2023 | Mar 31, 2022 | $636.16M | May 16, 2023 |
| FY2023 | Mar 31, 2021 | $467.18M | May 16, 2023 |
| FY2023 | Mar 31, 2020 | $338.49M | May 16, 2023 |
| FY2022 | Mar 31, 2019 | $409.63M | May 19, 2022 |
| FY2021 | Mar 31, 2018 | $369.82M | May 20, 2021 |
| FY2020 | Mar 31, 2017 | $304.88M | May 20, 2020 |
| FY2019 | Mar 31, 2016 | $210.71M | May 28, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Mar 31, 2018 | $600.00M | May 22, 2018 |
| FY2018 | Mar 31, 2017 | $300.00M | May 22, 2018 |
| FY2017 | Mar 31, 2016 | $300.00M | May 24, 2017 |
| FY2016 | Mar 31, 2015 | $0 | May 31, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | (5) | May 15, 2025 |
| FY2025 | Mar 31, 2024 | (2) | May 15, 2025 |
| FY2025 | Mar 31, 2023 | 0 | May 15, 2025 |
| FY2024 | Mar 31, 2022 | 0 | May 16, 2024 |
| FY2023 | Mar 31, 2021 | 0 | May 16, 2023 |
| FY2022 | Mar 31, 2020 | 0 | May 19, 2022 |
| FY2021 | Mar 31, 2019 | 0 | May 20, 2021 |
| FY2020 | Mar 31, 2018 | 0 | May 20, 2020 |
| FY2019 | Mar 31, 2017 | 0 | May 28, 2019 |
| FY2018 | Mar 31, 2016 | 0 | May 22, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | (5) | May 15, 2025 |
| FY2025 | Mar 31, 2024 | (2) | May 15, 2025 |
| FY2025 | Mar 31, 2023 | 0 | May 15, 2025 |
| FY2024 | Mar 31, 2022 | 0 | May 16, 2024 |
| FY2023 | Mar 31, 2021 | 0 | May 16, 2023 |
| FY2020 | Mar 31, 2020 | 0 | May 20, 2020 |
| FY2020 | Dec 31, 2019 | 0 | May 20, 2020 |
| FY2020 | Sep 30, 2019 | 0 | May 20, 2020 |
| FY2020 | Jun 30, 2019 | 0 | May 20, 2020 |
| FY2020 | Mar 31, 2019 | 0 | May 20, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 72.06M | May 15, 2025 |
| FY2025 | Mar 31, 2024 | 71.40M | May 15, 2025 |
| FY2024 | Mar 31, 2023 | 71.25M | May 16, 2024 |
| FY2023 | Mar 31, 2022 | 74.10M | May 16, 2023 |
| FY2022 | Mar 31, 2021 | 73.75M | May 19, 2022 |
| FY2021 | Mar 31, 2020 | 72.22M | May 20, 2021 |
| FY2020 | Mar 31, 2019 | 77.61M | May 20, 2020 |
| FY2019 | Mar 31, 2018 | 80.27M | May 28, 2019 |
| FY2018 | Mar 31, 2017 | 92.04M | May 22, 2018 |
| FY2017 | Mar 31, 2016 | 94.09M | May 24, 2017 |